Works matching IS 13518216 AND DT 2009 AND VI 15 AND IP 4


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII

    Published in:
    Haemophilia, 2009, v. 15, n. 4, p. 869, doi. 10.1111/j.1365-2516.2009.02027.x
    By:
    • RECHT, M.;
    • NEMES, L.;
    • MATYSIAK, M.;
    • MANCO-JOHNSON, M.;
    • LUSHER, J.;
    • SMITH, M.;
    • MANNUCCI, P.;
    • HAY, C.;
    • ABSHIRE, T.;
    • O’BRIEN, A.;
    • HAYWARD, B.;
    • UDATA, C.;
    • ROTH, D.A.;
    • ARKIN, S.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22